Cellular Targets of Propranolol in Infantile Hemangioma
Infantile hemangioma (IH) is a vascular neoplasm that affects 4-10 percent of infants. Propranolol, a non-selective beta-adrenergic receptor (AR) antagonist, was serendipitously discovered to accelerate regression of IH in 2008; however, its mechanism in IH is unclear.
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
Harvard University
2014
|
| Subjects: | |
| Online Access: | http://dissertations.umi.com/gsas.harvard:11218 http://nrs.harvard.edu/urn-3:HUL.InstRepos:11746172 |